Effective Achievement of Hemoglobin Stability with Once-Monthly C.E.R.A. in Peritoneal Dialysis Patients: A Prospective Study

被引：0
|
作者：
Michael Koch
Wolfgang Treiber
Danilo Fliser
机构：
[1] Nephrology Center,Department of Internal Medicine IV
[2] Renal and Hypertension Center Mittelrhein,undefined
[3] Saarland University,undefined
[4] Medical Centre,undefined
来源：
Clinical Drug Investigation | 2013年 / 33卷
关键词：
Peritoneal Dialysis; Hemodialysis Patient; Peritoneal Dialysis Patient; Darbepoetin Alfa; Erythropoiesis Stimulate Agent;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：699 / 706
页数：7
相关论文
共 39 条
  • [1] Effective Achievement of Hemoglobin Stability with Once-Monthly C.E.R.A. in Peritoneal Dialysis Patients: A Prospective Study
    Koch, Michael
    Treiber, Wolfgang
    Fliser, Danilo
    CLINICAL DRUG INVESTIGATION, 2013, 33 (10) : 699 - 706
  • [2] Fewer dose changes with once-monthly C.E.R.A. in patients with chronic kidney disease
    Mann, J. F. E.
    de Francisco, A.
    Nassar, G.
    Canaud, B.
    CLINICAL NEPHROLOGY, 2011, 76 (01) : 9 - 15
  • [3] STABILITY OF HEMOGLOBIN WITH ONCE-MONTHLY CERA INJECTIONS IN OLD DIALYSIS PATIENTS, HB DAY STUDY
    Seniuta, Piotr
    Baranger, Thierry
    Berge, Franck
    Drouillat, Valerie
    Frangie, Carlos
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 57 (04) : A86 - A86
  • [4] ONCE-MONTHLY PEGINESATIDE MAINTAINED HEMOGLOBIN LEVELS IN PERITONEAL DIALYSIS PATIENTS AFTER CONVERSION FROM EPOETIN
    Zabaneh, Raja
    Roger, Simon D.
    El-Shahawy, Mohamed
    Roppolo, Michael
    Runyan, Grant
    O'Neil, Janet
    Qiu, Ping
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 61 (04) : A100 - A100
  • [5] C.E.R.A. maintains stable hemoglobin in Latin American patients on dialysis
    Kleyton Bastos
    Luis Antonio Lucarelli
    Elizabeth De Francesco-Daher
    Roberto Pecoits Filho
    Carlos Henríquez
    Beatriz Espinoza
    Ignacio Villanueva
    Emma Schwedt
    Ruben Schiavelli
    Ricardo Correa-Rotter
    International Urology and Nephrology, 2013, 45 : 1355 - 1364
  • [6] Intravenous C.E.R.A. is as effective as standard epoetin in patients undergoing dialysis
    不详
    Nature Clinical Practice Nephrology, 2008, 4 (2): : 65 - 65
  • [7] Dosing strategies for conversion of haemodialysis patients from short-acting erythropoiesis stimulating agents to once-monthly C.E.R.A.: experience from the MIRACEL study
    Dellanna, F.
    Winkler, R. E.
    Bozkurt, F.
    Schettler, V.
    Graf, S.
    Bockreiss, N.
    Fliser, D.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2011, 65 (01) : 64 - 72
  • [8] Once-Monthly Continuous Erythropoietin Receptor Activator (C.E.R.A.) in Patients with Hemodialysis-Dependent Chronic Kidney Disease: Pooled Data from Phase III Trials
    Francesco Locatelli
    Gabriel Choukroun
    Matt Truman
    Alfons Wiggenhauser
    Danilo Fliser
    Advances in Therapy, 2016, 33 : 610 - 625
  • [9] Hemoglobin Stability and Patient Satisfaction After Switch to C.E.R.A. Therapy: A Multicenter, Observational Study
    Fuat Bozkurt
    Heribert-Ewald Fink
    Clinical Drug Investigation, 2013, 33 : 939 - 940
  • [10] Stable haemoglobin (Hb) levels are maintained with once-monthly C. E. R. A. in dialysis patients with varying C-reactive protein (CRP), albumin or dialysis adequacy
    Imbasciati, Enrico
    Bernardo, Marializa
    Caraman, Pierre-Louis
    David-Neto, Elias
    Harris, Kevin
    Law, Amy
    Dougherty, Frank C.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 412 - 412
1234